GeneralConnection.com ➔ Dictionary
Dictionary Search

mutate

Synonyms

Verb

1. change

Usage
KRAS G12D–Mutated Metastatic Pancreatic Cancer: Zoldonrasib Plus Chemotherapy - The ASCO Post
Hepatitis E viruses mutate early during infection - Medical Xpress
MARIPOSA Analysis: Amivantamab Plus Lazertinib Delays Time to Symptomatic Progression in EGFR-Mutated NSCLC - Cancer Nursing Today
Sleep and exercise may reduce mutation-driven inflammation - National Institutes of Health (NIH) | (.gov)
Mutating mice becoming growing problem in New York City, Rutgers researchers say - ABC7 New York
Mutating mice becoming growing problem in Philadelphia, Rutgers researchers say - 6abc Philadelphia
Adagrasib Plus Cetuximab Falls Short in KRAS G12C–Mutated Colorectal Cancer - Targeted Oncology
DEVO’s Duty Now for the Future: Mutate, Don’t Stagnate (Part 2 of 4) - Musoscribe
TP53 Status and Time Toxicity Shape Sequencing Decisions in EGFR-Mutated NSCLC - OncLive
TOP Trial: Chemo-Osimertinib in TP53-Mutant EGFR-Mutated NSCLC - CancerNetwork
What Do ASCO 2026 Data Mean for ESR1-Mutated Breast Cancer Care? - Oncology News Central
Palworld 1.0 Guide: How to Get Mutation Pals & Eggs - games.gg
Mutating rats, mice becoming resistant to poison, research suggests - NewsNation
Adagrasib plus cetuximab fails to outperform chemotherapy in KRAS G12C-mutated metastatic colorectal cancer - ESMO Daily Reporter
In ‘Mutate,’ a Leukemia Survivor Redefines Her Relationship With Dance - L.A. Dance Chronicle
DEVO’s Duty Now for the Future: Mutate, Don’t Stagnate (Part 4 of 4) - Musoscribe
Ziftomenib Expands Role in Relapsed/Refractory NPM1-Mutated AML - Targeted Oncology
“Still a Ways to Go”: Takeaways From ASCO 2026 in EGFR-Mutated NSCLC - Oncology News Central
DEVO’s Duty Now for the Future: Mutate, Don’t Stagnate (Part 1 of 4) - Musoscribe
DEVO’s Duty Now for the Future: Mutate, Don’t Stagnate (Part 3 of 4) - Musoscribe
Aumolertinib Plus Chemotherapy in EGFR -Mutated Advanced NSCLC - The ASCO Post
Astrazeneca Secures Global Rights To Zegfrovy In EGFR-mutated Lung Cancer - DirectorsTalk Interviews
Introduction and Frontline Treatment Options for EGFR-Mutated NSCLC - OncLive
VS-7375 Exhibits Activity in KRAS G12D–Mutated Solid Tumors - CancerNetwork
First-Line/Maintenance Ibrutinib Improves Survival in TP53-Mutated MCL - CancerNetwork
Heroin’s “Mutate or Die” Premiere Photos - Thrasher Magazine
Zongertinib, Sevabertinib Reshape Treatment Landscape for Patients With HER2-Mutated NSCLC - OncLive
Devo Perform in the Hudson Valley this Summer in their “Mutate, Don’t Stagnate” Tour - Chronogram Magazine
Hantavirus has not mutated to be more transmissible: WHO - The Hill
Mutating Mice in New York: The City’s Long War on Rodents Shows a New Twist - La Voce di New York
Heroin's "Mutate or Die" Video - Thrasher Magazine
Your DNA is changing all the time. Here’s why : Short Wave - NPR
Oral SERDs in ESR1-Mutated Disease: Clinical Differentiation and Use - Docwire News
Amivantamab Plus Lazertinib Improves Survival in Atypical EGFR-Mutated Advanced Non-Small Cell Lung Cancer - HMP Global Learning Network
Manchesterism is already starting to mutate - The Times
Gilteritinib Yields Comparable Efficacy vs Midostaurin in Newly Diagnosed FLT3-Mutated AML but Fails to Meet Phase 3 Primary End Point - OncLive
The Mutate God reflects on Raeford roots and more ahead of new release - The Fayetteville Observer
Integrated Molecular Analysis Identifies Determinants of Outcomes in TP53 -Mutated DLBCL - The ASCO Post
Camizestrant Extends PFS and PFS2 in ESR1-Mutated Advanced Breast Cancer - CancerNetwork
Daraxonrasib in Previously Treated Advanced RAS -Mutated Pancreatic Cancer - The New England Journal of Medicine
FDA Approves Companion Diagnostic for Inavolisib in HR+/HER2–, PIK3CA-Mutated Breast Cancer - OncLive
We Are All Constantly Mutating—and That’s a Good Thing - The New Yorker
Daraxonrasib for Previously Treated RAS -Mutated Pancreatic Cancer - The ASCO Post
Catching Cancer’s Earliest Moments: How Mutated Cells Transform Their Local Environment So a Tumor Can Develop - Memorial Sloan Kettering Cancer Center
Optimizing Targeted Therapy in Early-Stage EGFR-Mutated NSCLC - CancerNetwork
First-Line Onvansertib + Standard of Care Improves Antitumor Activity in RAS-Mutated mCRC - ASCO Daily News
Joel W. Neal, MD, PhD, on the CHRYSALIS-2 Study in Atypical EGFR-Mutated Advanced NSCLC - The ASCO Post
CHMP Recommends Camizestrant Plus CDK4/6 Inhibitor for ESR1-Mutated HR+ Advanced Breast Cancer - OncLive
FDA Grants Fast Track Designation to VS-7375 for KRAS G12D–Mutated NSCLC - Targeted Oncology
I’m Deeply Upset Subnautica 2 Won’t Let Me Mutate Into A Little Aquatic Freak - GameSpot
DEVO: Mutate Don’t Stagnate 6/12 at Borgata - 95.7 BEN FM
FDA Approves Vepdegestrant for ESR1-Mutated ER+/HER2− Advanced Breast Cancer - Targeted Oncology
Nuclear transcriptional condensates as drivers and therapeutic targets in NPM1-mutated AML - ScienceDirect.com
New FDA-Approved Targeted Therapy for ESR1-Mutated Metastatic Breast Cancer - news.cancerconnect.com
Future Directions and Unmet Needs in EGFR Mutated Metastatic Non-Small Cell Lung Cancer - CancerNetwork
Devo to wrap up their Mutate, Don’t Stagnate U.S. tour with August Orlando concert - Orlando Weekly
Navigating the Challenging Landscape of TP53-Mutated MDS and MPN - Targeted Oncology
FDA Approves Vepdegestrant for ER-Positive, HER2-Negative, ESR1-Mutated Advanced or Metastatic Breast Cancer - Oncology Nursing News
Frontline Sevabertinib Earns FDA Priority Review in HER2-Mutated NSCLC - CancerNetwork
EGFR-Mutated NSCLC: Mechanism and Clinical Role of TROP2-Directed ADCs - OncLive
AI-designed Vaccine Protects Against Viruses as they Mutate - Labcompare
Plixorafenib Receives FDA BTD for BRAF V600E–Mutated High-Grade Glioma - CancerNetwork
Amivantamab Plus Lazertinib Produces Clinically Meaningful OS in Atypical EGFR-Mutated Advanced NSCLC - OncLive
Ziftomenib Plus 7+3 Yields Strong Responses in NPM1-Mutated, KMT2A-Rearranged AML: Eunice S. Wang, MD - AJMC
DEVO: Mutate Don’t Stagnate - KRXI
Cardiff Onvansertib Shows 72% Response Rate in RAS-Mutated Colorectal Cancer - The Clinical Trial Vanguard
Talazoparib Plus Enzalutamide Delays Disease Progression in HRR-Mutated Metastatic Prostate Cancer - Clinical Oncology News
EGFR-Mutated NSCLC: Role of Value-Based Frameworks in Treatment Evaluation - OncLive
Unpacking the Advantages and Limitations of Leading Frontline Regimens in EGFR-Mutated NSCLC - OncLive
FDA Approves Vepdegestrant for ESR1-Mutated, ER-Positive, HER2-Negative Advanced Breast Cancer - AJMC
Post-HSCT Gilteritinib May Improve Outcomes in R/R FLT3-Mutated AML - Targeted Oncology
Head MTG designer explains why the Teenage Mutant Ninja Turtles don't mutate - wargamer.com
Sub-Q Amivantamab Offers Greater Convenience for Patients With EGFR-Mutated NSCLC: Estelamari Rodriguez, MD, MPH - AJMC
Less Is More: Advancing Care in TP53-Mutated Myeloid Malignancies - OncLive
Cardiff Oncology Advances Onvansertib Phase 3 for RAS-Mutated Metastatic Colorectal Cancer - The Clinical Trial Vanguard
EGFR-Mutated NSCLC: Emerging Role of TROP2-Directed Antibody–Drug Conjugates - OncLive
Scientists say rat virus is mutating – but no critical changes yet - The Telegraph
DEVO: Are We Not Entertained? Mutate, Don't Stagnate Tour at Caesars Windsor - 519 Magazine
Rezatapopt Generates Rapid, Durable Responses Across Subgroups in Pretreated TP53 Y220C–Mutated Ovarian Cancer - OncLive
Biopsy-Driven Neoadjuvant Planning in EGFR-Mutated NSCLC - CancerNetwork
Talazoparib Plus Enzalutamide Hits Primary End Point in HRR Gene–Mutated mCSPC - OncLive
Evolving Adjuvant Therapy in Early-Stage EGFR-Mutated NSCLC: Insights From ADAURA - CancerNetwork
Selecting Combination Versus Monotherapy in EGFR Mutated Metastatic Non-Small Cell Lung Cancer - CancerNetwork
Introduction to HER2-Mutated NSCLC: Defining the Clinical Landscape - OncLive
Cardiff Oncology Advances Onvansertib to Phase 3 for RAS-Mutated Colorectal Cancer - The Clinical Trial Vanguard
Adagrasib shows meaningful benefits in older patients with mutated NSCLC - ESMO Daily Reporter
Phase 1 Study of Rezatapopt, a p53 Reactivator, in TP53 Y220C–Mutated Tumors - The New England Journal of Medicine
Risk stratification of patients with TP53-mutated myeloproliferative neoplasms - Leukemia - Nature
Cardiff Oncology Advances Onvansertib Phase 3 for RAS-Mutated Colorectal Cancer - The Clinical Trial Vanguard
ctDNA Clearance Predicts Outcomes in KRAS G12C-Mutated Metastatic Colorectal Cancer - HMP Global Learning Network
EGFR-Mutated NSCLC: Molecular Reassessment at Disease Progression - OncLive
Subcutaneous Administration in EGFR Mutated Metastatic Non-Small Cell Lung Cancer - CancerNetwork
Evolving Frontline Treatment Options in EGFR-Mutated NSCLC - OncLive
Phase 3 TALAPRO-3 trial meets primary end point in HRR-mutated mCSPC - Urology Times
Screening of kinase inhibitors in the triple negative KRAS G13D-mutated MDA-MB-231 breast cancer cell line - Nature
Insomniac Launches MUTATE Records With Charlie Sparks & AZYR - EDMTunes
Zoldonrasib Displays Early Safety, Efficacy in Pretreated KRAS G12D–Mutated NSCLC - OncLive
Daraxonrasib Monotherapy Elicits Meaningful Responses in Previously Treated, RAS-Mutated Pancreatic Cancer - OncLive
Combination Approach Shows Benefit in Phase 3 EGFR-Mutated NSCLC Trial - Oncology News Central
Interpreting EGFR-TKI Evidence for Early-Stage EGFR-Mutated NSCLC - CancerNetwork
Foreign Language Equivalents
Foreign Language Equivalents of 'mutate'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
umtate,   mitate,   mmutate,   mutatee,   mytate,   mutat,   muatte,   muutate,   ,utate,   mtuate,   muyate,   mutae,   muate,   mutaate,   mutatr,   mutatte,   utate,   nutate,   mutaet,   mutare,   mutte,   muttate,   muttae,   mutaye,   murate,   mutatw,   mutste,   mtate
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z